Edition:
United Kingdom

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

5.35USD
15 Jun 2018
Change (% chg)

$0.08 (+1.52%)
Prev Close
$5.27
Open
$5.23
Day's High
$5.35
Day's Low
$5.23
Volume
13,534
Avg. Vol
9,995
52-wk High
$15.34
52-wk Low
$4.93

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $214.98
Shares Outstanding(Mil.): 14.71
Dividend: --
Yield (%): --

Financials

  ALRN.OQ Industry Sector
P/E (TTM): -- 84.11 32.75
EPS (TTM): -1.24 -- --
ROI: -- 1.56 14.38
ROE: -- 2.43 16.07

BRIEF-Aileron Therapeutics Q1 Loss Per Share $0.52

* AILERON THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share

* AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

02 Apr 2018

BRIEF-Aileron Therapeutics Appoints Jeffrey Bailey As Chairman Of Board

* AILERON THERAPEUTICS APPOINTS JEFFREY A. BAILEY TO ITS BOARD OF DIRECTORS

19 Mar 2018

BRIEF-Apple Tree Partners Sells 150,000 Shares Of Aileron Therapeutics Inc's Common Stock On Jan 9

* APPLE TREE PARTNERS II LP REPORTS SALE OF 150,000 SHARES OF AILERON THERAPEUTICS INC'S COMMON STOCK ON JAN 9 AT $9.80 PER SHARE - SEC FILING Source text: (http://bit.ly/2DiFGmF) Further company coverage:

11 Jan 2018

Earnings vs. Estimates